FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3080557615> ?p ?o ?g. }

• W3080557615 endingPage "593" @default.
• W3080557615 startingPage "586" @default.
• W3080557615 abstract "Reduction in sensitivity in terms of cytotoxicity is responsible for therapy failure in patients undergoing chemotherapy with first-line anticancer drug molecules. A plethora of literature evidence points out that increased O-linked β- N-acetylglucosamine transferase (OGT) enzyme level/hyper- O-GlcNAcylation has direct implications in development of cancer and interferes with clinical outcomes of chemotherapy via interaction with oncogenic factors. The aim of this research was to evaluate the combination approach of anticancer drugs with an OGT inhibitor (OSMI-1) as an alternative way to resolve issues in the treatment of prostate cancer and assess the benefits offered by this approach. Effect of combination of doxorubicin and docetaxel with OSMI-1 on drug-induced cell death and synergism/antagonism was investigated using resazurin assay. Reduction in OGT enzyme level was evaluated using ELISA kit. Caspase-3/7 fluorescence assay was performed to detect apoptosis induction in PC-3 cells after treatment with the combinations of doxorubicin and OGT inhibitor to further understand the mechanism of cell death by concomitant treatment. Studies reveal that combination approach is indeed effective in terms of reducing the half-maximum growth inhibition value of doxorubicin when concomitantly treated with OSMI-1 and has synergistic effect in prostate cancer cells. PC-3 cells exhibited elevated levels of OGT enzyme in comparison to WPMY-1, and OSMI-1 has potential to inhibit OGT enzyme significantly. Data show that OSMI-1 alone and in combination with doxorubicin reduces OGT enzyme level significantly accompanied by increased apoptosis in prostate cancer cells. Combination of doxorubicin with OSMI-1 reduced the elevated OGT level which led to a drastic increase in sensitivity of PC-3 cells toward doxorubicin in comparison to doxorubicin alone. This finding provides important insight regarding alternative treatment strategies for effective management of cancer." @default.
• W3080557615 created "2020-09-01" @default.
• W3080557615 creator A5030695851 @default.
• W3080557615 creator A5053478067 @default.
• W3080557615 creator A5078347227 @default.
• W3080557615 date "2020-08-27" @default.
• W3080557615 modified "2023-10-17" @default.
• W3080557615 title "Investigating the Impact of OGT Inhibition on Doxorubicin- and Docetaxel-Induced Cytotoxicity in PC-3 and WPMY-1 Cells" @default.
• W3080557615 cites W140399403 @default.
• W3080557615 cites W1854708637 @default.
• W3080557615 cites W196543165 @default.
• W3080557615 cites W1975483746 @default.
• W3080557615 cites W2020224261 @default.
• W3080557615 cites W2031711523 @default.
• W3080557615 cites W2037679360 @default.
• W3080557615 cites W2038294883 @default.
• W3080557615 cites W2042619042 @default.
• W3080557615 cites W2079492290 @default.
• W3080557615 cites W2080439368 @default.
• W3080557615 cites W2080462728 @default.
• W3080557615 cites W2085677500 @default.
• W3080557615 cites W2089049259 @default.
• W3080557615 cites W2106572206 @default.
• W3080557615 cites W2120292596 @default.
• W3080557615 cites W2134468405 @default.
• W3080557615 cites W2135072612 @default.
• W3080557615 cites W2145903740 @default.
• W3080557615 cites W2154677603 @default.
• W3080557615 cites W2172247109 @default.
• W3080557615 cites W2464384284 @default.
• W3080557615 cites W2594832232 @default.
• W3080557615 cites W2801429094 @default.
• W3080557615 cites W2889646458 @default.
• W3080557615 cites W2915499102 @default.
• W3080557615 cites W2938707984 @default.
• W3080557615 cites W2940601530 @default.
• W3080557615 cites W2982156914 @default.
• W3080557615 doi "https://doi.org/10.1177/1091581820948433" @default.
• W3080557615 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32851890" @default.
• W3080557615 hasPublicationYear "2020" @default.
• W3080557615 type Work @default.
• W3080557615 sameAs 3080557615 @default.
• W3080557615 citedByCount "10" @default.
• W3080557615 countsByYear W30805576152020 @default.
• W3080557615 countsByYear W30805576152021 @default.
• W3080557615 countsByYear W30805576152022 @default.
• W3080557615 countsByYear W30805576152023 @default.
• W3080557615 crossrefType "journal-article" @default.
• W3080557615 hasAuthorship W3080557615A5030695851 @default.
• W3080557615 hasAuthorship W3080557615A5053478067 @default.
• W3080557615 hasAuthorship W3080557615A5078347227 @default.
• W3080557615 hasBestOaLocation W30805576151 @default.
• W3080557615 hasConcept C109316439 @default.
• W3080557615 hasConcept C121608353 @default.
• W3080557615 hasConcept C126322002 @default.
• W3080557615 hasConcept C185592680 @default.
• W3080557615 hasConcept C190283241 @default.
• W3080557615 hasConcept C202751555 @default.
• W3080557615 hasConcept C2776694085 @default.
• W3080557615 hasConcept C2780192828 @default.
• W3080557615 hasConcept C2781190966 @default.
• W3080557615 hasConcept C2781303535 @default.
• W3080557615 hasConcept C31573885 @default.
• W3080557615 hasConcept C502942594 @default.
• W3080557615 hasConcept C55493867 @default.
• W3080557615 hasConcept C71924100 @default.
• W3080557615 hasConcept C96232424 @default.
• W3080557615 hasConcept C98274493 @default.
• W3080557615 hasConceptScore W3080557615C109316439 @default.
• W3080557615 hasConceptScore W3080557615C121608353 @default.
• W3080557615 hasConceptScore W3080557615C126322002 @default.
• W3080557615 hasConceptScore W3080557615C185592680 @default.
• W3080557615 hasConceptScore W3080557615C190283241 @default.
• W3080557615 hasConceptScore W3080557615C202751555 @default.
• W3080557615 hasConceptScore W3080557615C2776694085 @default.
• W3080557615 hasConceptScore W3080557615C2780192828 @default.
• W3080557615 hasConceptScore W3080557615C2781190966 @default.
• W3080557615 hasConceptScore W3080557615C2781303535 @default.
• W3080557615 hasConceptScore W3080557615C31573885 @default.
• W3080557615 hasConceptScore W3080557615C502942594 @default.
• W3080557615 hasConceptScore W3080557615C55493867 @default.
• W3080557615 hasConceptScore W3080557615C71924100 @default.
• W3080557615 hasConceptScore W3080557615C96232424 @default.
• W3080557615 hasConceptScore W3080557615C98274493 @default.
• W3080557615 hasFunder F4320334704 @default.
• W3080557615 hasIssue "6" @default.
• W3080557615 hasLocation W30805576151 @default.
• W3080557615 hasOpenAccess W3080557615 @default.
• W3080557615 hasPrimaryLocation W30805576151 @default.
• W3080557615 hasRelatedWork W2081815287 @default.
• W3080557615 hasRelatedWork W2129685713 @default.
• W3080557615 hasRelatedWork W2139614539 @default.
• W3080557615 hasRelatedWork W2201793188 @default.
• W3080557615 hasRelatedWork W236807388 @default.
• W3080557615 hasRelatedWork W2374053201 @default.
• W3080557615 hasRelatedWork W2419452664 @default.
• W3080557615 hasRelatedWork W2515537233 @default.
• W3080557615 hasRelatedWork W3095184244 @default.

• next